Table 5.
Crohn’s disease characteristics
| Elderly patients (EPs), n = 30 | Young patients (YPs) n = 60 | p | |
|---|---|---|---|
| Initial type of diagnosed IBD | 0.05 | ||
| Ulcerative colitis, n (%) | 8 (26.7%) | 5 (8.3%) | |
| Crohn’s disease, n (%) | 21 (70%) | 54 (90%) | |
| Indetermined colitis, n (%) | 1 (3.3%) | 1 (1.7%) | |
| Crohn’s disease localization* | 0.003 | ||
| L1 ileal, n (%) | 1 (3.3%) | 14 (23.3%) | |
| L2 colonic, n (%) | 21 (70%) | 20 (33.3%) | |
| L3 ileo-colonic, n (%) | 8 (26.7%) | 25 (41.7%) | |
| Anoperineal with no luminal involvement, n (%) | 0 (0%) | 1 (1.7%) | |
| Rectal involvement n (%) | 23 (76.7%) | 34 (56.7%) | 0.06 |
| Crohn’s disease phenotype* | 0.23 | ||
| B1 inflammatory, n (%) | 21 (70%) | 37 (61.7%) | |
| B2 stricturing§, n (%) | 3 (10%) | 16 (26.7%) | |
| B3 penetrating§, n (%) | 7 (23.3%) | 9 (15%) | |
| Extra-intestinal manifestations, n (%)‡ | 1 (3.3%) | 18 (30%) | 0.004 |
| rheumatological, n (%) | 0/1 (0%) | 11/18 (61.1%) | |
| skin/mucosal, n (%) | 0/1 (0%) | 8/18 (44.4%) | |
| Ocular, n (%) | 0/1 (0%) | 1/18 (5.6%) | |
| Other∫, n (%) | 1/1 (100%) | 0/18 (0%) |
IQR interquartile range, EPs age at first surgery ≥ 60, YPs age at first surgery < 60, IBD inflammatory bowel disease
*According to Montreal Classification12
§1 EP and 2 YPs had both stricturing and penetrating forms
‡2 patients had 2 types of extra-intestinal manifestations simultaneously: one presented with both cutaneous-mucosal and articular manifestations, while the other presented with ocular and articular manifestations
∫The only EP who had an extra-intestinal manifestation, had a diagnosis of primary sclerosing cholangitis